Home / PMCB : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does PMCB make money? Does PMCB have pricing power? What's the Earnings Whisper? Will PMCB profit more as the business scales? What is PMCB's management track record? Is PMCB's current price justified?

PharmaCyte Biotech, Inc.

$0.45 -$0.29 (-39.00%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$0.44

Day Range

$0.43$0.47

Year Range

$0.43$1.51

Market Cap

4.83M

AVG Volume

163.78K

Trailing/Forward PE

-0.15/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Net Income (USD)

PMCB Net Income (USD) by quarter
Period	Net Income (USD)
26 Q4	-4.39M
26 Q3	746.86K
26 Q2	-7.42M
26 Q1	-8.36M
25 Q4	11.75M
25 Q3	-3.05M
25 Q2	-1.47M
25 Q1	23.42M
24 Q4	1.35M
24 Q3	-620K

Operating Income (USD)

PMCB Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q4	-2.51M
26 Q3	-2.12M
26 Q2	-1.38M
26 Q1	-848.3K
25 Q4	-1.04M
25 Q3	-960.25K
25 Q2	-1.11M
25 Q1	-1.27M
24 Q4	-3.17M
24 Q3	-1.87M

EBITDA (USD)

PMCB EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q4	-961.83K
26 Q3	-2.12M
26 Q2	-1.38M
26 Q1	-848.3K
25 Q4	-1.04M
25 Q3	-960.25K
25 Q2	-1.11M
25 Q1	-1.27M
24 Q4	1.35M
24 Q3	-1.87M

Cash Flows (USD)

PMCB Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q4	-1.39M
26 Q3	-786.85K
26 Q2	-979.52K
26 Q1	-1.99M
25 Q4	-1.04M
25 Q3	-509.89K
25 Q2	-1.05M
25 Q1	-373.3K
24 Q4	-332.96K
24 Q3	-177.1K

EPS (USD)

PMCB EPS (USD) by quarter
Period	EPS (USD)
26 Q4	-0.46
26 Q3	-0.17
26 Q2	-1.24
26 Q1	-1.23
25 Q4	1.58
25 Q3	-0.44
25 Q2	-0.21
25 Q1	2.18
24 Q4	-0.3
24 Q3	-0.65

Expenses (USD)

PMCB Expenses (USD) by quarter
Period	Expenses (USD)
26 Q4	961.83K
26 Q3	2.12M
26 Q2	1.38M
26 Q1	848.3K
25 Q4	1.95M
25 Q3	960.25K
25 Q2	1.11M
25 Q1	1.27M
24 Q4	1.17M
24 Q3	1.87M

Cash & Debt (USD)

PMCB Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q4	37.08M
26 Q3	20.54M
26 Q2	15.61M
26 Q1	13.44M
25 Q4	15.54M
25 Q3	16.76M
25 Q2	20.84M
25 Q1	32.64M
24 Q4	50.18M
24 Q3	61.21M

Debt ratios

PMCB Debt ratios by quarter
Period	Debt ratios
26 Q4	6.99
26 Q3	3.81
26 Q2	3.69
26 Q1	3.4
25 Q4	3.55
25 Q3	8.43
25 Q2	7.2
25 Q1	10.2
24 Q4	12.53
24 Q3	11.17

Return on Capital

PMCB Return on Capital by quarter
Period	Return on Capital
26 Q4	-12.56%
26 Q3	1.9%
26 Q2	-20.29%
26 Q1	-19.18%
25 Q4	22.64%
25 Q3	-7.57%
25 Q2	-3.38%
25 Q1	44.16%
24 Q4	3.41%
24 Q3	-1.27%

Shares Outstanding

PMCB Shares Outstanding by quarter
Period	Shares Outstanding
26 Q4	9.61M
26 Q3	4.45M
26 Q2	5.99M
26 Q1	6.79M
25 Q4	6.85M
25 Q3	6.96M
25 Q2	6.94M
25 Q1	7.87M
24 Q4	8.04M
24 Q3	8.61M

Book Value Per Share (USD)

PMCB Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q4	3.64
26 Q3	8.86
26 Q2	6.1
26 Q1	6.42
25 Q4	7.57
25 Q3	5.78
25 Q2	6.26
25 Q1	6.74
24 Q4	4.92
24 Q3	5.68

Total Assets (USD)

PMCB Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q4	46.75M
26 Q3	55.87M
26 Q2	55.98M
26 Q1	45.11M
25 Q4	55.17M
25 Q3	43.83M
25 Q2	55.1M
25 Q1	70.19M
24 Q4	59.9M
24 Q3	71.36M

Employee Count

PMCB Employee Count by quarter
Period	Employee Count
2026	2
2025	2
2024	2
2023	2
2022	4
2021	4
2020	4
2019	4
2018	4
2017	4

PE Ratio

PMCB PE Ratio by quarter
Period	PE Ratio
Sep 25	0.23
Sep 25	0.21
Aug 25	0.21
Aug 25	0.22
Aug 25	0.2
Aug 25	0.29
Aug 25	0.34
Jul 25	0.33
Jul 25	0.35
Jul 25	0.37
Jul 25	0.38
Jun 25	0.35
Jun 25	0.36
Jun 25	0.35
Jun 25	0.35
May 25	0.35
May 25	0.36
May 25	0.36
May 25	0.38
May 25	0.42
Apr 25	0.42
Apr 25	0.41
Apr 25	0.42
Apr 25	0.43
Mar 25	0.45
Mar 25	0.54
Mar 25	0.48
Mar 25	0.54
Feb 25	0.54
Feb 25	0.54
Feb 25	0.5
Feb 25	0.46
Jan 25	0.49
Jan 25	0.5
Jan 25	0.52
Jan 25	0.47
Jan 25	0.5
Dec 24	0.48
Dec 24	0.5
Dec 24	0.53
Dec 24	0.48
Nov 24	0.5
Nov 24	0.5
Nov 24	0.48
Nov 24	0.53
Nov 24	0.53
Oct 24	0.53
Oct 24	0.5
Oct 24	0.51
Oct 24	0.52
Sep 24	0.54
Sep 24	0.47
Sep 24	45.73
Sep 24	38.26
Aug 24	36.82
Aug 24	39.95
Aug 24	45.24

Free Cash Flow Yield

PMCB Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-119.12%
Sep 26	-110.23%
Aug 26	-104.13%
Aug 26	-100.61%
Aug 26	-97.32%
Aug 26	-90.88%
Jul 26	-93.1%
Jul 26	-179.97%
Jul 26	-170.62%
Jul 26	-155.06%
Jul 26	-151.05%
Jun 26	-140.32%
Jun 26	-150.46%
Jun 26	-141.92%
Jun 26	-154.29%
May 26	-129.44%
May 26	-133.34%
May 26	-134.27%
May 26	-142.9%
May 26	-142.99%
Apr 26	-149.53%
Apr 26	-148.23%
Apr 26	-165.37%
Apr 26	-156.53%
Mar 26	-152.55%
Mar 26	-157.26%
Mar 26	-109.44%
Mar 26	-100.31%
Feb 26	-109.45%
Feb 26	-107.52%
Feb 26	-110.98%
Feb 26	-101.91%
Jan 26	-92.23%
Jan 26	-80.53%
Jan 26	-84.86%
Jan 26	-85.69%
Jan 26	-102.35%
Dec 25	-106.37%
Dec 25	-88.08%
Dec 25	-66.35%
Dec 25	-55.48%
Nov 25	-87.49%
Nov 25	-104.13%
Nov 25	-86%
Nov 25	-79.44%
Oct 25	-72.78%
Oct 25	-69.28%
Oct 25	-69.83%
Oct 25	-67.68%
Oct 25	-65.08%
Sep 25	-69.78%
Sep 25	-69.06%
Sep 25	-41.78%
Sep 25	-46.17%
Aug 25	-46.27%
Aug 25	-44.79%
Aug 25	-48.28%
Aug 25	-39.31%
Aug 25	-32.63%
Jul 25	-34.17%
Jul 25	-31.68%
Jul 25	-30.21%
Jul 25	-29.39%
Jun 25	-31.68%
Jun 25	-30.78%
Jun 25	-32.3%
Jun 25	-31.99%
May 25	-31.68%
May 25	-31.07%
May 25	-30.78%
May 25	-29.39%
May 25	-26.96%
Apr 25	-26.74%
Apr 25	-27.42%
Apr 25	-26.53%
Apr 25	-26.31%
Mar 25	-24.72%
Mar 25	-20.65%
Mar 25	-17.67%
Mar 25	-15.68%
Feb 25	-15.86%
Feb 25	-15.86%
Feb 25	-17.13%
Feb 25	-18.74%
Jan 25	-17.45%
Jan 25	-17.13%
Jan 25	-16.52%
Jan 25	-18.37%
Jan 25	-17.02%
Dec 24	-17.78%
Dec 24	-17.02%
Dec 24	-16.23%
Dec 24	-22.23%
Nov 24	-21.32%
Nov 24	-21.44%
Nov 24	-22.23%
Nov 24	-20.25%
Nov 24	-19.92%
Oct 24	-20.25%
Oct 24	-21.32%

EV/EBITDA

PMCB EV/EBITDA by quarter
Period	EV/EBITDA
Jul 22	-237.34
Jul 22	-241.85
Jul 22	-249.37
Jul 22	-264.4
Jun 22	-273.42
Jun 22	-279.44
Jun 22	-285.45
Jun 22	-271.92
May 22	-265.91
May 22	-267.41
May 22	-274.93
May 22	-267.41
Apr 22	-250.87
Apr 22	-277.93
Apr 22	-268.91
Apr 22	-264.4
Apr 22	-259.89
Mar 22	-243.36
Mar 22	-244.86
Mar 22	-498.46
Mar 22	-484.42
Feb 22	-519.54
Feb 22	-526.56
Feb 22	-505.49
Feb 22	-510.76
Jan 22	-512.51
Jan 22	-519.54
Jan 22	-454.56
Jan 22	-444.03
Dec 21	-440.52
Dec 21	-407.15
Dec 21	-445.78
Dec 21	41.58
Dec 21	39.41
Nov 21	41.14
Nov 21	43.53
Nov 21	48.3
Nov 21	50.47
Oct 21	48.08
Oct 21	46.56
Oct 21	52.85
Oct 21	56.11
Oct 21	55.89
Sep 21	58.49
Sep 21	65
Sep 21	46.48
Sep 21	42.42
Aug 21	44.34
Aug 21	44.13
Aug 21	39.65

Price to Book

PMCB Price to Book by quarter
Period	Price to Book
Sep 26	0.12
Sep 26	0.13
Aug 26	0.14
Aug 26	0.15
Aug 26	0.15
Aug 26	0.16
Jul 26	0.16
Jul 26	0.07
Jul 26	0.07
Jul 26	0.08
Jul 26	0.08
Jun 26	0.09
Jun 26	0.08
Jun 26	0.09
Jun 26	0.08
May 26	0.09
May 26	0.09
May 26	0.09
May 26	0.09
May 26	0.09
Apr 26	0.08
Apr 26	0.08
Apr 26	0.07
Apr 26	0.08
Mar 26	0.08
Mar 26	0.08
Mar 26	0.11
Mar 26	0.12
Feb 26	0.11
Feb 26	0.12
Feb 26	0.11
Feb 26	0.12
Jan 26	0.13
Jan 26	0.15
Jan 26	0.15
Jan 26	0.14
Jan 26	0.12
Dec 25	0.12
Dec 25	0.14
Dec 25	0.16
Dec 25	0.19
Nov 25	0.12
Nov 25	0.1
Nov 25	0.12
Nov 25	0.13
Oct 25	0.14
Oct 25	0.15
Oct 25	0.15
Oct 25	0.16
Oct 25	0.16
Sep 25	0.15
Sep 25	0.15
Sep 25	0.14
Sep 25	0.12
Aug 25	0.12
Aug 25	0.13
Aug 25	0.12
Aug 25	0.14
Aug 25	0.17
Jul 25	0.17
Jul 25	0.18
Jul 25	0.19
Jul 25	0.19
Jun 25	0.18
Jun 25	0.18
Jun 25	0.17
Jun 25	0.18
May 25	0.18
May 25	0.18
May 25	0.18
May 25	0.19
May 25	0.21
Apr 25	0.21
Apr 25	0.21
Apr 25	0.21
Apr 25	0.21
Mar 25	0.23
Mar 25	0.27
Mar 25	0.25
Mar 25	0.28
Feb 25	0.28
Feb 25	0.28
Feb 25	0.26
Feb 25	0.24
Jan 25	0.26
Jan 25	0.26
Jan 25	0.27
Jan 25	0.24
Jan 25	0.26
Dec 24	0.25
Dec 24	0.26
Dec 24	0.27
Dec 24	0.24
Nov 24	0.25
Nov 24	0.25
Nov 24	0.24
Nov 24	0.27
Nov 24	0.27
Oct 24	0.27
Oct 24	0.25

No video analysis for this stock yet. Request one from our team.

AI Analysis

PharmaCyte Biotech, Inc.

Video analysis: PMCB

Similar companies